| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, NAD(P)H as one donor, and incorporation of one atom of oxygen | 3.55e-05 | 40 | 32 | 3 | GO:0016709 | |
| GeneOntologyMolecularFunction | FAD binding | 4.73e-05 | 44 | 32 | 3 | GO:0071949 | |
| GeneOntologyMolecularFunction | NAD(P)H oxidase H2O2-forming activity | 1.63e-04 | 12 | 32 | 2 | GO:0016174 | |
| GeneOntologyMolecularFunction | phosphoserine residue binding | 1.63e-04 | 12 | 32 | 2 | GO:0050815 | |
| GeneOntologyMolecularFunction | flavin adenine dinucleotide binding | 4.54e-04 | 94 | 32 | 3 | GO:0050660 | |
| GeneOntologyMolecularFunction | oxidoreductase activity, acting on NAD(P)H, oxygen as acceptor | 4.64e-04 | 20 | 32 | 2 | GO:0050664 | |
| GeneOntologyMolecularFunction | monooxygenase activity | 8.17e-04 | 115 | 32 | 3 | GO:0004497 | |
| GeneOntologyMolecularFunction | MHC class II protein complex binding | 8.52e-04 | 27 | 32 | 2 | GO:0023026 | |
| GeneOntologyMolecularFunction | actin binding | 9.17e-04 | 479 | 32 | 5 | GO:0003779 | |
| GeneOntologyMolecularFunction | MHC protein complex binding | 1.96e-03 | 41 | 32 | 2 | GO:0023023 | |
| GeneOntologyBiologicalProcess | sulfur oxidation | 2.33e-06 | 2 | 32 | 2 | GO:0019417 | |
| GeneOntologyBiologicalProcess | actin filament depolymerization | 3.21e-06 | 66 | 32 | 4 | GO:0030042 | |
| GeneOntologyBiologicalProcess | protein depolymerization | 7.04e-05 | 144 | 32 | 4 | GO:0051261 | |
| GeneOntologyBiologicalProcess | calcium ion export across plasma membrane | 1.52e-04 | 12 | 32 | 2 | GO:1990034 | |
| Domain | FAD_binding_3 | 8.25e-08 | 6 | 31 | 3 | PF01494 | |
| Domain | FAD-bd | 8.25e-08 | 6 | 31 | 3 | IPR002938 | |
| Domain | KRAB_RELATED | 6.77e-07 | 11 | 31 | 3 | PS50806 | |
| Domain | Krueppel-associated_box-rel | 1.17e-06 | 13 | 31 | 3 | IPR003655 | |
| Domain | CH | 3.92e-06 | 65 | 31 | 4 | SM00033 | |
| Domain | CH | 5.27e-06 | 70 | 31 | 4 | PF00307 | |
| Domain | - | 5.58e-06 | 71 | 31 | 4 | 1.10.418.10 | |
| Domain | CH | 6.24e-06 | 73 | 31 | 4 | PS50021 | |
| Domain | CH-domain | 6.95e-06 | 75 | 31 | 4 | IPR001715 | |
| Domain | SSX | 3.98e-05 | 6 | 31 | 2 | IPR028804 | |
| Domain | 14_3_3 | 5.57e-05 | 7 | 31 | 2 | SM00101 | |
| Domain | 1433_1 | 5.57e-05 | 7 | 31 | 2 | PS00796 | |
| Domain | 1433_2 | 5.57e-05 | 7 | 31 | 2 | PS00797 | |
| Domain | DUF3585 | 5.57e-05 | 7 | 31 | 2 | PF12130 | |
| Domain | 14-3-3_domain | 5.57e-05 | 7 | 31 | 2 | IPR023410 | |
| Domain | 14-3-3_CS | 5.57e-05 | 7 | 31 | 2 | IPR023409 | |
| Domain | 14-3-3 | 5.57e-05 | 7 | 31 | 2 | PF00244 | |
| Domain | DUF3585 | 5.57e-05 | 7 | 31 | 2 | IPR022735 | |
| Domain | 14-3-3 | 7.42e-05 | 8 | 31 | 2 | IPR000308 | |
| Domain | SSXRD | 7.42e-05 | 8 | 31 | 2 | PF09514 | |
| Domain | SSXRD_motif | 7.42e-05 | 8 | 31 | 2 | IPR019041 | |
| Domain | - | 1.08e-04 | 56 | 31 | 3 | 3.50.50.60 | |
| Domain | FAD/NAD-binding_dom | 1.14e-04 | 57 | 31 | 3 | IPR023753 | |
| Domain | LIM | 2.01e-04 | 69 | 31 | 3 | PF00412 | |
| Domain | - | 2.10e-04 | 70 | 31 | 3 | 2.10.110.10 | |
| Domain | LIM_DOMAIN_2 | 2.19e-04 | 71 | 31 | 3 | PS50023 | |
| Domain | Znf_LIM | 2.19e-04 | 71 | 31 | 3 | IPR001781 | |
| Domain | LIM_DOMAIN_1 | 2.19e-04 | 71 | 31 | 3 | PS00478 | |
| Domain | LIM | 2.19e-04 | 71 | 31 | 3 | SM00132 | |
| Domain | KRAB | 2.77e-03 | 358 | 31 | 4 | PF01352 | |
| Domain | KRAB | 3.09e-03 | 369 | 31 | 4 | SM00349 | |
| Domain | KRAB | 3.12e-03 | 370 | 31 | 4 | IPR001909 | |
| Domain | Ig_E-set | 1.29e-02 | 104 | 31 | 2 | IPR014756 | |
| Pathway | PID_PI3KCI_AKT_PATHWAY | 1.32e-05 | 35 | 19 | 3 | M249 | |
| Pathway | PID_FOXO_PATHWAY | 3.68e-05 | 49 | 19 | 3 | M136 | |
| Pathway | KEGG_EPITHELIAL_CELL_SIGNALING_IN_HELICOBACTER_PYLORI_INFECTION | 9.84e-05 | 68 | 19 | 3 | M16848 | |
| Pathway | REACTOME_SARS_COV_2_TARGETS_HOST_INTRACELLULAR_SIGNALLING_AND_REGULATORY_PATHWAYS | 1.13e-04 | 12 | 19 | 2 | M45022 | |
| Pathway | REACTOME_CHK1_CHK2_CDS1_MEDIATED_INACTIVATION_OF_CYCLIN_B_CDK1_COMPLEX | 1.13e-04 | 12 | 19 | 2 | MM15443 | |
| Pathway | REACTOME_ACTIVATION_OF_BAD_AND_TRANSLOCATION_TO_MITOCHONDRIA | 1.13e-04 | 12 | 19 | 2 | MM14482 | |
| Pathway | KEGG_MEDICUS_PATHOGEN_HCV_CORE_TO_ERK_SIGNALING_PATHWAY | 1.33e-04 | 13 | 19 | 2 | M47589 | |
| Pathway | REACTOME_CHK1_CHK2_CDS1_MEDIATED_INACTIVATION_OF_CYCLIN_B_CDK1_COMPLEX | 1.33e-04 | 13 | 19 | 2 | M27708 | |
| Pathway | REACTOME_ACTIVATION_OF_BAD_AND_TRANSLOCATION_TO_MITOCHONDRIA | 1.79e-04 | 15 | 19 | 2 | M26902 | |
| Pathway | REACTOME_MAP3K8_TPL2_DEPENDENT_MAPK1_3_ACTIVATION | 2.04e-04 | 16 | 19 | 2 | M27567 | |
| Pathway | REACTOME_SARS_COV_1_TARGETS_HOST_INTRACELLULAR_SIGNALLING_AND_REGULATORY_PATHWAYS | 2.04e-04 | 16 | 19 | 2 | M46428 | |
| Pathway | WP_VEGFAVEGFR2_SIGNALING | 2.13e-04 | 431 | 19 | 5 | M39729 | |
| Pathway | REACTOME_ACTIVATION_OF_BH3_ONLY_PROTEINS | 2.60e-04 | 18 | 19 | 2 | MM14510 | |
| Pathway | REACTOME_SIGNALING_BY_HIPPO | 3.22e-04 | 20 | 19 | 2 | MM14813 | |
| Pathway | REACTOME_SIGNALING_BY_HIPPO | 3.22e-04 | 20 | 19 | 2 | M591 | |
| Pathway | WP_17P133_YWHAE_COPY_NUMBER_VARIATION | 3.56e-04 | 21 | 19 | 2 | M48088 | |
| Pathway | PID_P38_MK2_PATHWAY | 3.56e-04 | 21 | 19 | 2 | M199 | |
| Pathway | PID_ERBB1_DOWNSTREAM_PATHWAY | 3.57e-04 | 105 | 19 | 3 | M164 | |
| Pathway | REACTOME_RHO_GTPASES_ACTIVATE_PKNS | 4.28e-04 | 23 | 19 | 2 | MM15216 | |
| Pathway | BIOCARTA_TOLL_PATHWAY | 4.67e-04 | 24 | 19 | 2 | MM1518 | |
| Pathway | BIOCARTA_STRESS_PATHWAY | 4.67e-04 | 24 | 19 | 2 | MM1515 | |
| Pathway | BIOCARTA_STRESS_PATHWAY | 4.67e-04 | 24 | 19 | 2 | M9670 | |
| Pathway | BIOCARTA_TOLL_PATHWAY | 5.07e-04 | 25 | 19 | 2 | M984 | |
| Pathway | PID_INSULIN_GLUCOSE_PATHWAY | 5.49e-04 | 26 | 19 | 2 | M247 | |
| Pathway | PID_TRAIL_PATHWAY | 6.37e-04 | 28 | 19 | 2 | M79 | |
| Pathway | PID_PDGFRB_PATHWAY | 6.52e-04 | 129 | 19 | 3 | M186 | |
| Pathway | REACTOME_ACTIVATION_OF_BH3_ONLY_PROTEINS | 7.32e-04 | 30 | 19 | 2 | M17814 | |
| Pathway | PID_HDAC_CLASSII_PATHWAY | 9.41e-04 | 34 | 19 | 2 | M30 | |
| Pathway | WP_CALCIUM_REGULATION_IN_CARDIAC_CELLS | 9.52e-04 | 147 | 19 | 3 | MM15854 | |
| Pathway | WP_CALCIUM_REGULATION_IN_CARDIAC_CELLS | 1.03e-03 | 151 | 19 | 3 | M39329 | |
| Pathway | WP_HEPATITIS_B_INFECTION | 1.03e-03 | 151 | 19 | 3 | M39801 | |
| Pathway | PID_PI3K_PLC_TRK_PATHWAY | 1.06e-03 | 36 | 19 | 2 | M271 | |
| Pathway | WP_PDGF_PATHWAY | 1.30e-03 | 40 | 19 | 2 | M39555 | |
| Pathway | REACTOME_INTRINSIC_PATHWAY_FOR_APOPTOSIS | 1.30e-03 | 40 | 19 | 2 | MM14473 | |
| Pathway | REACTOME_MUSCLE_CONTRACTION | 1.33e-03 | 165 | 19 | 3 | MM15026 | |
| Pathway | BIOCARTA_KERATINOCYTE_PATHWAY | 1.72e-03 | 46 | 19 | 2 | MM1428 | |
| Pathway | PID_A6B1_A6B4_INTEGRIN_PATHWAY | 1.72e-03 | 46 | 19 | 2 | M239 | |
| Pathway | BIOCARTA_KERATINOCYTE_PATHWAY | 1.72e-03 | 46 | 19 | 2 | M19118 | |
| Pathway | PID_LKB1_PATHWAY | 1.79e-03 | 47 | 19 | 2 | M87 | |
| Pathway | WP_INTERLEUKIN1_IL1_STRUCTURAL_PATHWAY | 1.95e-03 | 49 | 19 | 2 | M39543 | |
| Pathway | SIG_INSULIN_RECEPTOR_PATHWAY_IN_CARDIAC_MYOCYTES | 2.11e-03 | 51 | 19 | 2 | M7955 | |
| Pathway | PID_NFAT_3PATHWAY | 2.28e-03 | 53 | 19 | 2 | M113 | |
| Pathway | REACTOME_MUSCLE_CONTRACTION | 2.40e-03 | 203 | 19 | 3 | M5485 | |
| Pathway | REACTOME_SARS_COV_2_HOST_INTERACTIONS | 2.44e-03 | 204 | 19 | 3 | M45011 | |
| Pathway | WP_IL1_SIGNALING | 2.45e-03 | 55 | 19 | 2 | M39346 | |
| Pathway | WP_CARDIAC_HYPERTROPHIC_RESPONSE | 2.45e-03 | 55 | 19 | 2 | M39685 | |
| Pathway | REACTOME_INTRINSIC_PATHWAY_FOR_APOPTOSIS | 2.45e-03 | 55 | 19 | 2 | M7455 | |
| Pathway | REACTOME_INTERLEUKIN_17_SIGNALING | 2.81e-03 | 59 | 19 | 2 | MM15128 | |
| Pathway | PID_FCER1_PATHWAY | 2.91e-03 | 60 | 19 | 2 | M7 | |
| Pathway | WP_ALPHA_6_BETA_4_INTEGRIN_SIGNALING_PATHWAY | 3.51e-03 | 66 | 19 | 2 | MM15925 | |
| Pathway | SIG_PIP3_SIGNALING_IN_CARDIAC_MYOCTES | 3.61e-03 | 67 | 19 | 2 | M295 | |
| Pathway | PID_P75_NTR_PATHWAY | 3.72e-03 | 68 | 19 | 2 | M153 | |
| Pathway | PID_MTOR_4PATHWAY | 3.83e-03 | 69 | 19 | 2 | M121 | |
| Pathway | REACTOME_CELLULAR_RESPONSES_TO_STIMULI | 4.02e-03 | 828 | 19 | 5 | M27827 | |
| Pathway | REACTOME_INTERLEUKIN_17_SIGNALING | 4.05e-03 | 71 | 19 | 2 | M27382 | |
| Pathway | REACTOME_G2_M_DNA_DAMAGE_CHECKPOINT | 4.16e-03 | 72 | 19 | 2 | MM15381 | |
| Pathway | REACTOME_TRANSLOCATION_OF_SLC2A4_GLUT4_TO_THE_PLASMA_MEMBRANE | 4.16e-03 | 72 | 19 | 2 | M26954 | |
| Pathway | REACTOME_TP53_REGULATES_METABOLIC_GENES | 4.27e-03 | 73 | 19 | 2 | MM15223 | |
| Pubmed | Redox modification of nuclear actin by MICAL-2 regulates SRF signaling. | 2.83e-09 | 4 | 32 | 3 | 24440334 | |
| Pubmed | The MICAL proteins and rab1: a possible link to the cytoskeleton? | 2.83e-09 | 4 | 32 | 3 | 15694364 | |
| Pubmed | 7.07e-09 | 5 | 32 | 3 | 12110185 | ||
| Pubmed | Inhibitory interaction of the plasma membrane Na+/Ca2+ exchangers with the 14-3-3 proteins. | 2.47e-08 | 7 | 32 | 3 | 16679322 | |
| Pubmed | ATP6V1A MICAL1 MAP2K4 MICAL3 C12orf50 YWHAB YWHAE MICAL2 RPL7 SPTBN2 | 3.79e-07 | 1431 | 32 | 10 | 37142655 | |
| Pubmed | A directed protein interaction network for investigating intracellular signal transduction. | 5.34e-07 | 1124 | 32 | 9 | 21900206 | |
| Pubmed | 8.20e-07 | 2 | 32 | 2 | 15735574 | ||
| Pubmed | 8.20e-07 | 2 | 32 | 2 | 21935479 | ||
| Pubmed | [Analysis of SYT/SSX1 and SYT/SSX2 fusion genes from synovial sarcoma]. | 8.20e-07 | 2 | 32 | 2 | 22393780 | |
| Pubmed | Differential regulation of actin microfilaments by human MICAL proteins. | 8.20e-07 | 2 | 32 | 2 | 22331357 | |
| Pubmed | A novel fluorescence in situ hybridization assay for synovial sarcoma. | 8.20e-07 | 2 | 32 | 2 | 23623359 | |
| Pubmed | 9.30e-07 | 21 | 32 | 3 | 12216073 | ||
| Pubmed | 14-3-3beta binds to big mitogen-activated protein kinase 1 (BMK1/ERK5) and regulates BMK1 function. | 2.46e-06 | 3 | 32 | 2 | 14679215 | |
| Pubmed | 2.46e-06 | 3 | 32 | 2 | 23615913 | ||
| Pubmed | 2.46e-06 | 3 | 32 | 2 | 24130893 | ||
| Pubmed | 2.46e-06 | 3 | 32 | 2 | 7539744 | ||
| Pubmed | 2.46e-06 | 3 | 32 | 2 | 7655467 | ||
| Pubmed | Gene expression profiles relate to SS18/SSX fusion type in synovial sarcoma. | 2.46e-06 | 3 | 32 | 2 | 16152617 | |
| Pubmed | Recurrent and novel SS18-SSX fusion transcripts in synovial sarcoma: description of three new cases. | 2.46e-06 | 3 | 32 | 2 | 22976541 | |
| Pubmed | SS18-SSX fusion protein-induced Wnt/β-catenin signaling is a therapeutic target in synovial sarcoma. | 2.46e-06 | 3 | 32 | 2 | 24166495 | |
| Pubmed | 4.69e-06 | 484 | 32 | 6 | 31995728 | ||
| Pubmed | Co-existence of SYT-SSX1 and SYT-SSX2 fusions in synovial sarcomas. | 4.92e-06 | 4 | 32 | 2 | 12037676 | |
| Pubmed | 4.92e-06 | 4 | 32 | 2 | 16968670 | ||
| Pubmed | Mammalian and yeast 14-3-3 isoforms form distinct patterns of dimers in vivo. | 4.92e-06 | 4 | 32 | 2 | 12507503 | |
| Pubmed | 4.92e-06 | 4 | 32 | 2 | 7951320 | ||
| Pubmed | 4.92e-06 | 4 | 32 | 2 | 15173315 | ||
| Pubmed | Cleavage of 14-3-3 protein by caspase-3 facilitates bad interaction with Bcl-x(L) during apoptosis. | 4.92e-06 | 4 | 32 | 2 | 12657644 | |
| Pubmed | The RAS effector RIN1 directly competes with RAF and is regulated by 14-3-3 proteins. | 4.92e-06 | 4 | 32 | 2 | 11784866 | |
| Pubmed | Anchoring of both PKA and 14-3-3 inhibits the Rho-GEF activity of the AKAP-Lbc signaling complex. | 4.92e-06 | 4 | 32 | 2 | 15229649 | |
| Pubmed | Interaction of 14-3-3 with Bid during seizure-induced neuronal death. | 4.92e-06 | 4 | 32 | 2 | 12871587 | |
| Pubmed | 6.54e-06 | 513 | 32 | 6 | 25798074 | ||
| Pubmed | Tumor suppressor BAP1 nuclear import is governed by transportin-1. | 7.19e-06 | 1149 | 32 | 8 | 35446349 | |
| Pubmed | 8.19e-06 | 5 | 32 | 2 | 16227609 | ||
| Pubmed | Structural basis for protein-protein interactions in the 14-3-3 protein family. | 8.19e-06 | 5 | 32 | 2 | 17085597 | |
| Pubmed | 8.19e-06 | 5 | 32 | 2 | 11985497 | ||
| Pubmed | 8.19e-06 | 5 | 32 | 2 | 18687683 | ||
| Pubmed | Interaction between human BAP31 and respiratory syncytial virus small hydrophobic (SH) protein. | 8.19e-06 | 5 | 32 | 2 | 25854864 | |
| Pubmed | 8.19e-06 | 5 | 32 | 2 | 23938468 | ||
| Pubmed | A Cdc2-related protein kinase hPFTAIRE1 from human brain interacting with 14-3-3 proteins. | 8.19e-06 | 5 | 32 | 2 | 16775625 | |
| Pubmed | Isoform-specific cleavage of 14-3-3 proteins in apoptotic JURL-MK1 cells. | 8.19e-06 | 5 | 32 | 2 | 19173300 | |
| Pubmed | 8.19e-06 | 5 | 32 | 2 | 23911929 | ||
| Pubmed | 14-3-3 Proteins regulate exonuclease 1-dependent processing of stalled replication forks. | 8.19e-06 | 5 | 32 | 2 | 21533173 | |
| Pubmed | Two-Dimensional Fractionation Method for Proteome-Wide Cross-Linking Mass Spectrometry Analysis. | 9.81e-06 | 847 | 32 | 7 | 35235311 | |
| Pubmed | 1.23e-05 | 6 | 32 | 2 | 25588844 | ||
| Pubmed | 1.23e-05 | 6 | 32 | 2 | 26947017 | ||
| Pubmed | 1.23e-05 | 6 | 32 | 2 | 16613846 | ||
| Pubmed | 1.23e-05 | 6 | 32 | 2 | 9369453 | ||
| Pubmed | alpha-Synuclein shares physical and functional homology with 14-3-3 proteins. | 1.23e-05 | 6 | 32 | 2 | 10407019 | |
| Pubmed | 1.23e-05 | 6 | 32 | 2 | 7644510 | ||
| Pubmed | Hepatitis C virus core protein interacts with 14-3-3 protein and activates the kinase Raf-1. | 1.23e-05 | 6 | 32 | 2 | 10644344 | |
| Pubmed | Specific interaction between 14-3-3 isoforms and the human CDC25B phosphatase. | 1.23e-05 | 6 | 32 | 2 | 10713667 | |
| Pubmed | 1.23e-05 | 6 | 32 | 2 | 10681541 | ||
| Pubmed | NudCL2 regulates cell migration by stabilizing both myosin-9 and LIS1 with Hsp90. | 1.27e-05 | 333 | 32 | 5 | 32665550 | |
| Pubmed | 1.30e-05 | 1247 | 32 | 8 | 27684187 | ||
| Pubmed | 1.72e-05 | 7 | 32 | 2 | 10441394 | ||
| Pubmed | 14-3-3 and erlin proteins differentially interact with RIPK2 complexes. | 1.72e-05 | 7 | 32 | 2 | 34152391 | |
| Pubmed | Interaction of apoptosis signal-regulating kinase 1 with isoforms of 14-3-3 proteins. | 1.72e-05 | 7 | 32 | 2 | 15023544 | |
| Pubmed | 1.72e-05 | 7 | 32 | 2 | 17369396 | ||
| Pubmed | The expression of seven 14-3-3 isoforms in human meningioma. | 1.72e-05 | 7 | 32 | 2 | 20388496 | |
| Pubmed | 1.72e-05 | 7 | 32 | 2 | 10559254 | ||
| Pubmed | 1.72e-05 | 7 | 32 | 2 | 22588126 | ||
| Pubmed | Identification of five novel 14-3-3 isoforms interacting with the GPIb-IX complex in platelets. | 1.72e-05 | 7 | 32 | 2 | 19558434 | |
| Pubmed | SLITRK1 binds 14-3-3 and regulates neurite outgrowth in a phosphorylation-dependent manner. | 1.72e-05 | 7 | 32 | 2 | 19640509 | |
| Pubmed | 1.72e-05 | 7 | 32 | 2 | 27030597 | ||
| Pubmed | 1.72e-05 | 7 | 32 | 2 | 21390248 | ||
| Pubmed | A nonphosphorylated 14-3-3 binding motif on exoenzyme S that is functional in vivo. | 1.72e-05 | 7 | 32 | 2 | 12383250 | |
| Pubmed | Cytosolic sequestration of spatacsin by Protein Kinase A and 14-3-3 proteins. | 1.72e-05 | 7 | 32 | 2 | 36096339 | |
| Pubmed | 1.72e-05 | 7 | 32 | 2 | 10869435 | ||
| Pubmed | The cyclin-dependent kinase 11 interacts with 14-3-3 proteins. | 1.72e-05 | 7 | 32 | 2 | 15883043 | |
| Pubmed | 1.72e-05 | 7 | 32 | 2 | 16868027 | ||
| Pubmed | 1.72e-05 | 7 | 32 | 2 | 31906564 | ||
| Pubmed | Protein binding and signaling properties of RIN1 suggest a unique effector function. | 2.29e-05 | 8 | 32 | 2 | 9144171 | |
| Pubmed | 2.29e-05 | 8 | 32 | 2 | 36503900 | ||
| Pubmed | TAZ, a transcriptional modulator of mesenchymal stem cell differentiation. | 2.29e-05 | 8 | 32 | 2 | 16099986 | |
| Pubmed | 2.29e-05 | 8 | 32 | 2 | 15708996 | ||
| Pubmed | Phosphorylation of human keratin 18 serine 33 regulates binding to 14-3-3 proteins. | 2.29e-05 | 8 | 32 | 2 | 9524113 | |
| Pubmed | 14-3-3 proteins interact with a hybrid prenyl-phosphorylation motif to inhibit G proteins. | 2.29e-05 | 8 | 32 | 2 | 23622247 | |
| Pubmed | 2.29e-05 | 8 | 32 | 2 | 8702721 | ||
| Pubmed | 2.29e-05 | 8 | 32 | 2 | 12007189 | ||
| Pubmed | 2.29e-05 | 8 | 32 | 2 | 16045749 | ||
| Pubmed | 2.29e-05 | 8 | 32 | 2 | 30468767 | ||
| Pubmed | 2.29e-05 | 8 | 32 | 2 | 18332103 | ||
| Pubmed | Phosphorylation of MDMX mediated by Akt leads to stabilization and induces 14-3-3 binding. | 2.29e-05 | 8 | 32 | 2 | 18356162 | |
| Pubmed | 2.94e-05 | 9 | 32 | 2 | 18458160 | ||
| Pubmed | MUC1 oncoprotein blocks nuclear targeting of c-Abl in the apoptotic response to DNA damage. | 2.94e-05 | 9 | 32 | 2 | 16888623 | |
| Pubmed | 14-3-3-protein regulates Nedd4-2 by modulating interactions between HECT and WW domains. | 2.94e-05 | 9 | 32 | 2 | 34294877 | |
| Pubmed | 2.94e-05 | 9 | 32 | 2 | 16581770 | ||
| Pubmed | Regulation of MDMX nuclear import and degradation by Chk2 and 14-3-3. | 2.94e-05 | 9 | 32 | 2 | 16511560 | |
| Pubmed | 2.94e-05 | 9 | 32 | 2 | 12446771 | ||
| Pubmed | 14-3-3 interacts with the tumor suppressor tuberin at Akt phosphorylation site(s). | 2.94e-05 | 9 | 32 | 2 | 12438239 | |
| Pubmed | 2.94e-05 | 9 | 32 | 2 | 29118970 | ||
| Pubmed | Identification and characterization of the interaction between tuberin and 14-3-3zeta. | 2.94e-05 | 9 | 32 | 2 | 12176984 | |
| Pubmed | 14-3-3 suppresses the nuclear localization of threonine 157-phosphorylated p27(Kip1). | 2.94e-05 | 9 | 32 | 2 | 15057270 | |
| Pubmed | 2.94e-05 | 9 | 32 | 2 | 14611804 | ||
| Pubmed | 3.26e-05 | 67 | 32 | 3 | 29357390 | ||
| Pubmed | Identifying biological pathways that underlie primordial short stature using network analysis. | 3.32e-05 | 1024 | 32 | 7 | 24711643 | |
| Pubmed | Involvement of protein kinase PKN1 in G2/M delay caused by arsenite. | 3.67e-05 | 10 | 32 | 2 | 15791647 | |
| Pubmed | 14-3-3ε and NAV2 interact to regulate neurite outgrowth and axon elongation. | 3.67e-05 | 10 | 32 | 2 | 24161943 | |
| Pubmed | Protein phosphatase 1 binds to phospho-Ser-1394 of the macrophage-stimulating protein receptor. | 3.67e-05 | 10 | 32 | 2 | 14505491 | |
| Pubmed | 14-3-3 proteins play a role in the cell cycle by shielding cdt2 from ubiquitin-mediated degradation. | 3.67e-05 | 10 | 32 | 2 | 25154416 | |
| Interaction | SLC8A2 interactions | 1.48e-06 | 15 | 31 | 3 | int:SLC8A2 | |
| Interaction | SLC8A3 interactions | 2.21e-06 | 17 | 31 | 3 | int:SLC8A3 | |
| Interaction | MAP3K3 interactions | 8.11e-06 | 84 | 31 | 4 | int:MAP3K3 | |
| Interaction | NCAM2 interactions | 1.30e-05 | 30 | 31 | 3 | int:NCAM2 | |
| Interaction | KCTD13 interactions | ATP6V1A MICAL1 MAP2K4 MICAL3 C12orf50 YWHAB YWHAE MICAL2 RPL7 SPTBN2 | 2.81e-05 | 1394 | 31 | 10 | int:KCTD13 |
| Interaction | FOXO3 interactions | 3.78e-05 | 124 | 31 | 4 | int:FOXO3 | |
| Interaction | DMTN interactions | 4.18e-05 | 44 | 31 | 3 | int:DMTN | |
| Interaction | SASH1 interactions | 6.15e-05 | 50 | 31 | 3 | int:SASH1 | |
| Interaction | KCNK15 interactions | 6.38e-05 | 8 | 31 | 2 | int:KCNK15 | |
| Interaction | KCNK9 interactions | 8.19e-05 | 9 | 31 | 2 | int:KCNK9 | |
| Interaction | SMN1 interactions | 8.61e-05 | 299 | 31 | 5 | int:SMN1 | |
| Interaction | SH3RF3 interactions | 8.64e-05 | 56 | 31 | 3 | int:SH3RF3 | |
| Interaction | SHANK3 interactions | 9.41e-05 | 496 | 31 | 6 | int:SHANK3 | |
| Interaction | OTOG interactions | 1.02e-04 | 10 | 31 | 2 | int:OTOG | |
| Interaction | DOCK9 interactions | 1.12e-04 | 61 | 31 | 3 | int:DOCK9 | |
| Interaction | HLA-DRB4 interactions | 1.50e-04 | 12 | 31 | 2 | int:HLA-DRB4 | |
| Interaction | PPP1R3E interactions | 1.50e-04 | 12 | 31 | 2 | int:PPP1R3E | |
| Interaction | GNGT2 interactions | 1.50e-04 | 12 | 31 | 2 | int:GNGT2 | |
| Interaction | PDE7B interactions | 1.50e-04 | 12 | 31 | 2 | int:PDE7B | |
| Interaction | DLGAP1 interactions | 1.60e-04 | 180 | 31 | 4 | int:DLGAP1 | |
| Interaction | MAP3K10 interactions | 1.61e-04 | 69 | 31 | 3 | int:MAP3K10 | |
| Interaction | KCNK3 interactions | 1.77e-04 | 13 | 31 | 2 | int:KCNK3 | |
| Interaction | VIM interactions | 1.78e-04 | 804 | 31 | 7 | int:VIM | |
| Interaction | MAP3K2 interactions | 1.91e-04 | 73 | 31 | 3 | int:MAP3K2 | |
| Interaction | MATCAP2 interactions | 2.06e-04 | 14 | 31 | 2 | int:MATCAP2 | |
| Interaction | SLC8A1 interactions | 2.06e-04 | 14 | 31 | 2 | int:SLC8A1 | |
| Interaction | NEK4 interactions | 2.25e-04 | 582 | 31 | 6 | int:NEK4 | |
| Interaction | ARL3 interactions | 2.32e-04 | 78 | 31 | 3 | int:ARL3 | |
| Interaction | LY6G5C interactions | 2.37e-04 | 15 | 31 | 2 | int:LY6G5C | |
| Interaction | LGALS9 interactions | 2.38e-04 | 588 | 31 | 6 | int:LGALS9 | |
| Interaction | SAMSN1 interactions | 2.71e-04 | 16 | 31 | 2 | int:SAMSN1 | |
| Interaction | TESPA1 interactions | 2.71e-04 | 16 | 31 | 2 | int:TESPA1 | |
| Interaction | ZNF395 interactions | 3.07e-04 | 17 | 31 | 2 | int:ZNF395 | |
| Interaction | FAM53B interactions | 3.45e-04 | 18 | 31 | 2 | int:FAM53B | |
| Interaction | RIPK2 interactions | 3.77e-04 | 92 | 31 | 3 | int:RIPK2 | |
| Interaction | AFAP1L1 interactions | 3.85e-04 | 19 | 31 | 2 | int:AFAP1L1 | |
| Interaction | FAM163A interactions | 3.85e-04 | 19 | 31 | 2 | int:FAM163A | |
| Interaction | DLEU1 interactions | 4.28e-04 | 20 | 31 | 2 | int:DLEU1 | |
| Interaction | PARP8 interactions | 4.28e-04 | 20 | 31 | 2 | int:PARP8 | |
| Interaction | MLXIP interactions | 4.28e-04 | 20 | 31 | 2 | int:MLXIP | |
| Interaction | NUDCD2 interactions | 4.36e-04 | 424 | 31 | 5 | int:NUDCD2 | |
| Interaction | MICALL1 interactions | 4.41e-04 | 97 | 31 | 3 | int:MICALL1 | |
| Interaction | KIF5A interactions | 4.54e-04 | 98 | 31 | 3 | int:KIF5A | |
| Interaction | MAP3K20 interactions | 4.68e-04 | 99 | 31 | 3 | int:MAP3K20 | |
| Interaction | SPATA13 interactions | 4.72e-04 | 21 | 31 | 2 | int:SPATA13 | |
| Interaction | STOX2 interactions | 4.72e-04 | 21 | 31 | 2 | int:STOX2 | |
| Interaction | SPIRE2 interactions | 4.72e-04 | 21 | 31 | 2 | int:SPIRE2 | |
| Interaction | DENND1B interactions | 4.72e-04 | 21 | 31 | 2 | int:DENND1B | |
| Interaction | MYO9A interactions | 4.96e-04 | 101 | 31 | 3 | int:MYO9A | |
| Interaction | ATAT1 interactions | 5.19e-04 | 22 | 31 | 2 | int:ATAT1 | |
| Interaction | PPP1R3D interactions | 5.19e-04 | 22 | 31 | 2 | int:PPP1R3D | |
| Interaction | PDE7A interactions | 5.19e-04 | 22 | 31 | 2 | int:PDE7A | |
| Interaction | PPP4R4 interactions | 5.19e-04 | 22 | 31 | 2 | int:PPP4R4 | |
| Interaction | GSTA1 interactions | 5.19e-04 | 22 | 31 | 2 | int:GSTA1 | |
| Interaction | CCSER1 interactions | 5.68e-04 | 23 | 31 | 2 | int:CCSER1 | |
| Interaction | GLCCI1 interactions | 5.68e-04 | 23 | 31 | 2 | int:GLCCI1 | |
| Interaction | ARRB2 interactions | 5.94e-04 | 454 | 31 | 5 | int:ARRB2 | |
| Interaction | PACS2 interactions | 6.19e-04 | 24 | 31 | 2 | int:PACS2 | |
| Interaction | E2F8 interactions | 6.19e-04 | 24 | 31 | 2 | int:E2F8 | |
| Interaction | CNTLN interactions | 6.19e-04 | 24 | 31 | 2 | int:CNTLN | |
| Interaction | BAP1 interactions | 6.53e-04 | 1314 | 31 | 8 | int:BAP1 | |
| Interaction | CDC14A interactions | 6.53e-04 | 111 | 31 | 3 | int:CDC14A | |
| Interaction | HJURP interactions | 6.53e-04 | 111 | 31 | 3 | int:HJURP | |
| Interaction | GSK3A interactions | 6.56e-04 | 464 | 31 | 5 | int:GSK3A | |
| Interaction | TMCC1 interactions | 6.72e-04 | 25 | 31 | 2 | int:TMCC1 | |
| Interaction | LNP1 interactions | 6.72e-04 | 25 | 31 | 2 | int:LNP1 | |
| Interaction | C6orf132 interactions | 6.72e-04 | 25 | 31 | 2 | int:C6orf132 | |
| Interaction | MYCBP interactions | 6.88e-04 | 113 | 31 | 3 | int:MYCBP | |
| Interaction | CALD1 interactions | 6.95e-04 | 265 | 31 | 4 | int:CALD1 | |
| Interaction | PDE3B interactions | 7.24e-04 | 115 | 31 | 3 | int:PDE3B | |
| Interaction | PLEKHM3 interactions | 7.27e-04 | 26 | 31 | 2 | int:PLEKHM3 | |
| Interaction | FAM83G interactions | 7.27e-04 | 26 | 31 | 2 | int:FAM83G | |
| Interaction | MAST4 interactions | 7.27e-04 | 26 | 31 | 2 | int:MAST4 | |
| Interaction | PIK3R4 interactions | 7.80e-04 | 118 | 31 | 3 | int:PIK3R4 | |
| Interaction | SPIRE1 interactions | 7.85e-04 | 27 | 31 | 2 | int:SPIRE1 | |
| Interaction | KIF23 interactions | 8.01e-04 | 1031 | 31 | 7 | int:KIF23 | |
| Interaction | AAK1 interactions | 8.39e-04 | 121 | 31 | 3 | int:AAK1 | |
| Interaction | MAP3K8 interactions | 8.44e-04 | 28 | 31 | 2 | int:MAP3K8 | |
| Interaction | CARMIL2 interactions | 8.44e-04 | 28 | 31 | 2 | int:CARMIL2 | |
| Interaction | SPATA18 interactions | 8.44e-04 | 28 | 31 | 2 | int:SPATA18 | |
| Interaction | USP31 interactions | 8.44e-04 | 28 | 31 | 2 | int:USP31 | |
| Interaction | WWC2 interactions | 8.44e-04 | 28 | 31 | 2 | int:WWC2 | |
| Interaction | RGL2 interactions | 8.44e-04 | 28 | 31 | 2 | int:RGL2 | |
| Interaction | KIAA0930 interactions | 8.44e-04 | 28 | 31 | 2 | int:KIAA0930 | |
| Interaction | DENND2B interactions | 8.44e-04 | 28 | 31 | 2 | int:DENND2B | |
| Interaction | FAM13A interactions | 9.06e-04 | 29 | 31 | 2 | int:FAM13A | |
| Interaction | RICTOR interactions | 9.20e-04 | 759 | 31 | 6 | int:RICTOR | |
| Interaction | HLA-DRB5 interactions | 9.70e-04 | 30 | 31 | 2 | int:HLA-DRB5 | |
| Interaction | TICRR interactions | 9.70e-04 | 30 | 31 | 2 | int:TICRR | |
| Interaction | MAGEC2 interactions | 9.70e-04 | 30 | 31 | 2 | int:MAGEC2 | |
| Interaction | ARAP2 interactions | 9.70e-04 | 30 | 31 | 2 | int:ARAP2 | |
| Interaction | ZFP36L1 interactions | 9.70e-04 | 30 | 31 | 2 | int:ZFP36L1 | |
| Interaction | STAC interactions | 9.70e-04 | 30 | 31 | 2 | int:STAC | |
| Interaction | PABIR1 interactions | 1.04e-03 | 31 | 31 | 2 | int:PABIR1 | |
| Interaction | MAP3K9 interactions | 1.04e-03 | 31 | 31 | 2 | int:MAP3K9 | |
| Interaction | ALS2 interactions | 1.04e-03 | 31 | 31 | 2 | int:ALS2 | |
| Interaction | RASGRF1 interactions | 1.04e-03 | 31 | 31 | 2 | int:RASGRF1 | |
| Interaction | CRTC1 interactions | 1.04e-03 | 31 | 31 | 2 | int:CRTC1 | |
| Interaction | MACIR interactions | 1.04e-03 | 31 | 31 | 2 | int:MACIR | |
| Interaction | AKT1S1 interactions | 1.10e-03 | 32 | 31 | 2 | int:AKT1S1 | |
| Cytoband | 22q13.1 | 1.62e-03 | 85 | 32 | 2 | 22q13.1 | |
| Cytoband | Xp11.23 | 2.02e-03 | 95 | 32 | 2 | Xp11.23 | |
| Cytoband | 6q21 | 2.06e-03 | 96 | 32 | 2 | 6q21 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chrXp11 | 2.28e-03 | 377 | 32 | 3 | chrXp11 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr6q21 | 3.24e-03 | 121 | 32 | 2 | chr6q21 | |
| GeneFamily | 14-3-3 phospho-serine/phospho-threonine binding proteins | 2.69e-05 | 7 | 21 | 2 | 1053 | |
| GeneFamily | LIM domain containing | 4.21e-05 | 59 | 21 | 3 | 1218 | |
| GeneFamily | Pleckstrin homology domain containing|Rho guanine nucleotide exchange factors|C2 domain containing | 2.35e-02 | 206 | 21 | 2 | 682 | |
| Coexpression | MYLLYKANGAS_AMPLIFICATION_HOT_SPOT_1 | 1.89e-05 | 6 | 30 | 2 | M5931 | |
| Disease | synovial sarcoma | 1.40e-05 | 6 | 29 | 2 | C0039101 | |
| Disease | chronic widespread pain | 2.33e-04 | 23 | 29 | 2 | EFO_0010099 | |
| Disease | Parkinson Disease | 3.17e-03 | 85 | 29 | 2 | C0030567 | |
| Disease | brain ischemia (biomarker_via_orthology) | 4.52e-03 | 102 | 29 | 2 | DOID:2316 (biomarker_via_orthology) | |
| Disease | forced expiratory volume | 7.08e-03 | 789 | 29 | 4 | EFO_0004314 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| ESKVFYYKMKGDYHR | 116 | P62258 | |
| NEYFSTKYKIMRKYD | 71 | P0DKL9 | |
| SKVFYLKMKGDYFRY | 116 | P31946 | |
| SEYKRMYGKSLYHDI | 471 | P50995 | |
| SMHDYRYFVSKFETK | 361 | Q9Y3Q7 | |
| MSTSFDKFYKYVYSV | 181 | P45985 | |
| KSHYKVDYSRFHKTY | 326 | P48050 | |
| YYKDDTHYFVMTAKK | 291 | Q7RTP6 | |
| SYMVYLFDKSKTVYE | 381 | O15111 | |
| EYYYKMKFFTKCVAF | 251 | Q9P2M1 | |
| YYKDDTHYFVMTAKK | 286 | Q8TDZ2 | |
| THKKKRKHSSDDYYY | 71 | Q9UGU5 | |
| YEKAKHYHKEYRQMY | 51 | P18124 | |
| TYYSSLGDYMKYIHK | 291 | Q5VUJ5 | |
| LHYMKKLYKTYATKE | 86 | O60383 | |
| YYKDCTHYFVMTAKK | 291 | O94851 | |
| KMLTFTYKYISSFGY | 1336 | Q5TCS8 | |
| KYSEKISYVYMKRNY | 41 | Q16384 | |
| YYYLKHQTVKMFKDR | 1821 | Q8N3C0 | |
| KEMCYKSGEYYRFHT | 116 | Q8NA57 | |
| KLLYSMKESTTKYYF | 371 | Q8TCY9 | |
| TYVATYYHYFSKMKA | 271 | O15020 | |
| KASEKIFYVYMKRKY | 41 | Q16385 | |
| KYSEKISYVYMKRNY | 41 | Q7RTT4 | |
| HTKTKYTYYYGKRKK | 656 | Q5VUG0 | |
| ESLKDFNMYFYHYSK | 826 | Q8IWV7 | |
| KYMRALDEYYDKHFT | 456 | P38606 | |
| FRMSSHHYDYKKYGK | 421 | P59923 | |
| YNYYKKFSYKTIVMG | 221 | P37837 | |
| KYYSTKHFSSKRKYD | 1056 | Q9BXT5 | |
| ADKRLLFYKYMHKKY | 251 | P57103 | |
| LFYKYMHKKYRTDKH | 256 | P57103 | |
| KHIKDTRYMSSYFKY | 4971 | P20929 | |
| TRYMSSYFKYKEAYE | 4976 | P20929 |